Kimberly A. Hartwell

Author

Also Known As

Fatima Al-Shahrour, K Hartwell, K. HARTWELL, Kimberly A Hartwell, Kimberly A. Hartwell, Kimberly Hartwell, Kimberly A. Hartwell

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Harvard University Brigham and Women's Hospital Broad Institute Massachusetts Institute of Technology Dana-Farber Cancer Institute

About

Kimberly A. Hartwell is an author at Harvard University specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.2K
2	Health Sciences	1	1	93
3	Natural Sciences	1	1	38
4	Biochemistry	1	1	38
5	Biostatistics	1	1	38

Kimberly A. Hartwell

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes Joseph H. Taube, Jason I. Herschkowitz, Kakajan Komurov, Proceedings of the National Academy of Sciences	2010	1K
Mesenchyme Forkhead 1 ( <i>FOXC2</i> ) plays a key role in metastasis and is associated with aggressive basal-like breast cancers Sendurai A. Mani, Jing Yang, Mary W. Brooks, Proceedings of the National Academy of Sciences Breast OncologyKey RolePathologyCancer BiologyGene Expression Profiling	2007	576
Immortalization and transformation of primary human airway epithelial cells by gene transfer Ante S. Lundberg, Scott H. Randell, Sheila A. Stewart, Oncogene Human CellCell LineageDevelopmental BiologyHuman TissueMedicine	2002	257
The Spemann organizer gene, <i>Goosecoid</i> , promotes tumor metastasis Kimberly A. Hartwell, Beth Muir, Ferenc Reinhardt, Proceedings of the National Academy of Sciences	2006	217
In Vivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling Peter G. Miller, Fátima Al‐Shahrour, Kimberly A. Hartwell, Cancer Cell Hematological MalignancyCancer ResearchLeukemia-specific DependenceMedicineImmunology	2013	162
Niche-based screening identifies small-molecule inhibitors of leukemia stem cells Kimberly A. Hartwell, Peter G. Miller, Siddhartha Mukherjee, Nature Chemical Biology Hematological MalignancyMixed-phenotype Acute LeukemiaStem Cell ResearchLeukemia Stem CellsMedicine	2013	108
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia Marcus Järås, Peter G. Miller, Lisa P. Chu, The Journal of Experimental Medicine Mixed-phenotype Acute LeukemiaImmunologyShrna ScreenCancer BiologyTumor Biology	2014	93
Connecting Small Molecules with Similar Assay Performance Profiles Leads to New Biological Hypotheses Vlado Dančík, Hyman A. Carrel, Nicole E. Bodycombe, SLAS DISCOVERY New Biological HypothesesHit IdentificationMolecular BiologyChemical BiologyBioanalysis	2014	38
Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors Shrikanta Chattopadhyay, Alison L Stewart, Siddhartha Mukherjee, Cell Reports	2015	29

Page 1